Skip to main content
. 2018 Apr-Jun;7(2):127–131. doi: 10.4103/sajc.sajc_118_18

Table 4.

Question 1 (III) - In BRCA1/2 positive cases, will you consider poly (adenosine diphosphate.ribose) polymerase inhibitors?

graphic file with name SAJC-7-127-g004.jpg